SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Saamya Biotech (India) informs about summary of proceedings of EGM

03 Apr 2017 Evaluate

Saamya Biotech (India) has informed that the Extra Ordinary General Meeting (EGM) of the company was held on April 03, 2017 at 9.00 A.M at Registered office of the company at 104-106, Lumbini Enclave, Panjagutta, Hyderabad, Telangana-500082. The company has enclosed the Summary of proceedings of the EGM, as required under Regulation 30, Part-A of Schedule -III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Annexure A).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×